Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: MOLINDONE HYDROCHLORIDE — Supplemental Application (EPIC PHARMA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for molindone hydrochloride, a generic antipsychotic, submitted by Epic Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Molindone Hydrochloride (molindone hydrochloride)

Snippet

SUPPL AP for MOLINDONE HYDROCHLORIDE (MOLINDONE HYDROCHLORIDE)